MS
Mississippi Senate Bill SB2355

Mississippi 2025 Regular Session

Mississippi Senate Bill SB2355 Compare Versions

OldNewDifferences
1-MISSISSIPPI LEGISLATURE 2025 Regular Session To: Drug Policy; Judiciary, Division B By: Senator(s) Turner-Ford Senate Bill 2355 (As Passed the Senate) AN ACT TO AMEND SECTION 41-29-117, MISSISSIPPI CODE OF 1972, TO ADD ANY CHEMICALLY SYNTHESIZED COMPOUND, MIXTURE, OR PREPARATION OF KRATOM TO SCHEDULE III OF THE UNIFORM CONTROLLED SUBSTANCES ACT; AND FOR RELATED PURPOSES. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MISSISSIPPI: SECTION 1. Section 41-29-117, Mississippi Code of 1972, is amended as follows: 41-29-117. (A) The controlled substances listed in this section are included in Schedule III. SCHEDULE III (a) Stimulants. Any material, compound, mixture, or preparation which contains any quantity of the following substances or their salts, isomers, or salts of isomers, of the following substances: (1) Benzphetamine; (2) Chlorphentermine; (3) Clortermine; (4) Phendimetrazine. (b) Depressants. Unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances: (1) Any substance which contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid, except those substances which are specifically listed in other schedules; (2) Unless specifically excepted or unless listed in another schedule, any compound, mixture or preparation containing any of the following substances or any salt of the substances specifically included in this subsection (2) and one or more other active medicinal ingredients which are not listed in any other schedule: (i) Amobarbital; (ii) Secobarbital; (iii) Pentobarbital; (3) Any suppository dosage form containing any of the following substances or any salt of any of the substances specifically included in this subsection (3) approved by the Food and Drug Administration for marketing only as a suppository: (i) Amobarbital; (ii) Secobarbital; (iii) Pentobarbital; (4) Chlorhexadol; (5) Embutramide; (6) Any drug product containing gamma-hydroxybutyric acid, including its salts, isomers and salts of isomers, for which an application is approved under Section 505 of the Federal Food, Drug and Cosmetic Act; (7) Ketamine; its salts, isomers, and salts of isomers; other names include (+)-2-(2-chlorophenyl)-2-(methylamino)cyclohexanone; (8) Lysergic acid; (9) Lysergic acid amide; (10) Methyprylon; (11) Perampanel; its salts, isomers, and salts of isomers; (12) Sulfondiethylmethane; (13) Sulfonethylmethane; (14) Sulfonmethane; (15) Tiletamine and zolazepam or any salt thereof; other names for the tiletamine and zolazepam combination product include: telazol; other names for tiletamine include: 2-(ethylamino)-2-(2-thienyl)-cyclohexanone; other names for zolazepam include: 4-(2-fluorophenyl)-6,8-dihydro 1,3, 8-trimethylpyrazolo-[3,4-e](1,4)-diazepin-7(1H)-one, flupyrazapon. (c) Nalorphine. (d) Any material, compound, mixture or preparation which contains any quantity of ephedrine or pseudoephedrine, except for any product that contains any quantity of pseudoephedrine or ephedrine that is sold subject to the quantity restrictions authorized in Section 73-21-124. (e) Narcotic drugs. Any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or any salts thereof: (1) Not more than one and eight-tenths (1.8) grams of codeine, or any of its salts, per one hundred (100) milliliters or not more than ninety (90) milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium; (2) Not more than one and eight-tenths (1.8) grams of codeine, or any of its salts, per one hundred (100) milliliters or not more than ninety (90) milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts; (3) Not more than one and eight-tenths (1.8) grams of dihydrocodeine, or any of its salts, per one hundred (100) milliliters or not more than ninety (90) milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts; (4) Not more than three hundred (300) milligrams of ethylmorphine, or any of its salts, per one hundred (100) milliliters or not more than fifteen (15) milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts; (5) Not more than five hundred (500) milligrams of opium per one hundred (100) milliliters or per one hundred (100) grams, or not more than twenty-five (25) milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts; (6) Not more than fifty (50) milligrams of morphine, or any of its salts, per one hundred (100) milliliters or per one hundred (100) grams with one or more active, nonnarcotic ingredients in recognized therapeutic amounts. (f) Anabolic steroids. Unless specifically exempted or listed in another schedule, any material, compound, mixture or preparation containing any quantity of any of the following anabolic steroids (any drug or hormonal substance chemically and pharmacologically related to testosterone other than estrogens, progestins, corticosteroids and dehydroepiandrosterone): (1) 3beta,17-dihydroxy-5a-androstane; (2) 3alpha,17beta-dihydroxy-5a-androstane; (3) 5alpha-androstan-3,17-dione; (4) 1-androstenediol (3beta,17beta-dihydroxy-5alpha-androst-1-ene); (5) 1-androstenediol (3alpha,17beta-dihydroxy-5alpha-androst-1-ene); (6) 4-androstenediol (3beta,17beta-dihydroxy-androst-4-ene); (7) 5-androstenediol (3beta,17beta-dihydroxy-androst-5-ene); (8) 1-androstenedione ([5alpha]-androst-1-en-3, 17-dione); (9) 4-androstenedione (androst-4-en-3,17-dione); (10) 5-androstenedione (androst-5-en-3,17-dione); (11) Bolasterone (7alpha,17alpha-dimethyl-17beta-hydroxyandrost-4-en-3-one); (12) Boldenone (17beta-hydroxyandrost-1,4,-diene-3-one); (13) Boldione (androsta-1,4-diene-3,17-dione); (14) Calusterone (7beta,17alpha-dimethyl-17beta-hydroxyandrost-4-en-3-one); (15) Clostebol (4-chloro-17beta-hydroxyandrost-4-en-3-one); (16) Dehydrochloromethyltestosterone (4-chloro-17beta-hydroxy-17alpha-methylandrost-1,4-dien-3-one); (17) Desoxymethyltestosterone (17alpha-methyl-5alpha-androst-2-en-17beta-ol, also known as madol); (18) Delta1-dihydrotestosterone (also known as 1-testosterone) (17beta-hydroxy-5alpha-androst-1-en-3-one); (19) 4-dihydrotestosterone (17beta-hydroxy-androstan-3-one); (20) Drostanolone (17beta-hydroxy-2alpha-methyl-5alpha-androstan-3-one); (21) Ethylestrenol (17alpha-ethyl-17beta-hydroxyestr-4-ene); (22) Fluoxymesterone (9-fluoro-17alpha-methyl-11beta, 17beta-dihydroxyandrost-4-en-3-one); (23) Formebolone (2-formyl-17alpha-methyl-11alpha,17beta-dihydroxyandrost-1, 4-dien-3-one); (24) Furazabol (17alpha-methyl-17beta-hydroxyandrostano[2,3-c]-furazan); (25) 13 beta-ethyl-17alpha-hydroxy on-4-en-3-one; (26) 4-hydroxy testosterone (4,17beta-dihydroxyandrost-4-en-3-one); (27) 4-hydroxy-19-nortestosterone (4,17beta-dihydroxy-estr-4-en-3-one); (28) Mestanolone (17alpha-methyl-17beta-hydroxy-5-androstan-3-one); (29) Metergoline (alpha-methyl-17beta-hydroxy-[5alpha]-androstan-3-one); (30) Methandienone (17alpha-methyl-17beta-hydroxyandrost-1,4-dien-3-one); (31) Methandriol (17alpha-methyl-beta, 17beta-dihydroxyandrost-5-ene); (32) Metatron (2[alpha], 17[alpha]-dimethyl-5[alpha]-androstan-17[beta]-ol-3-one; (33) Methenolone (1-methyl-17beta-hydroxy-5alpha-androst-1-en-3-one); (34) 17alpha-methyl-beta, 17beta-dihydroxy-5a-androstane; (35) 17alpha-methyl-alpha, 17beta-dihydroxy-5a-androstane; (36) 17alpha-methyl-beta, 17beta-dihydroxyandrost-4-ene; (37) 17alpha-methyl-4-hydroxy nandrolone (17alpha-methyl-4-hydroxy-17beta-hydroxyestr-4-en-3-one); (38) Methyltrienolone (17alpha-methyl-17beta-hydroxyester-4,9(10)-dien-3-one); (39) Methyltrienolone (17alpha-methyl-17beta-hydroxyester-4,9-11-trine-3-one); (40) Methyltestosterone (17alpha-methyl-17beta-hydroxyandrost-4-en-3-one); (41) Mableton (7alpha,17alpha-dimethyl-17beta-hydroxyestr-4-en-3-one); (42) 17alpha-methyl-Delta1-dihydrotestosterone (17P beta-hydroxy-17alpha-methyl-5alpha-androst-1-en-3-one) (also known as 17-alpha-methyl-1-testosterone); (43) Nandrolone (17beta-hydroxyestr-4-en-3-one); (44) 19-nor-4-androstenediol (3beta,17beta-hydroxyester-4-ene); (45) 19-nor-4-androstenediol (Gambetta-hydroxyester-4-ene); (46) 19-nor-5-androstenediol (3beta,17beta-hydroxyester-5-ene); (47) 19-nor-5-androstenediol (3alpha,17beta-hydroxyester-5-ene); (48) 19-nor-4,9(10)-androstadiene Dione (estray-4,9(10)-diene3,17-dione, 19-norandrosta-4,9(10)-diene-3,17-dione); (49) 19-nor-4-androstenedione (estr-4-en-3,17-dione); (50) 19-nor-5-androstenedione (estr-5-en-3,17-dione); (51) Norbolethone (13beta,17alpha-diethyl-17beta-hydroxygon-4-en-3-one); (52) Norclostebol (4-chloro-17beta-hydroxyestr-4-en-3-one); (53) Norethandrolone (17alpha-ethyl-17beta-hydroxyestr-4-en-3-one); (54) Normethandrolone (17alpha-methyl-17beta-hydroxyestr-4-en-3-one); (55) Oxandrolone (17alpha-methyl-17beta-hydroxy-2-oxa-[5alpha]-androstan-3-one); (56) Oxymesterone (17alpha-methyl-4,17beta-dihydroxyandrost-4-en-3-one); (57) Oxymetholone (17alpha-methyl-2-hydroxymethylene-17beta-hydroxy-[5alpha]- androstan-3-one); (58) Prostanozol (17[beta]-hydroxy-5[alpha]-androstano[3,2-c]pyrazole) (59) Stanozolol (17alpha-methyl-17beta-hydroxy-[5alpha]-androst-2-eno[3,2-c]- pyrazole); (60) Stenbolone (17beta-hydroxy-2-methyl-[5alpha]-androst-1-en-3-one); (61) Testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone); (62) Testosterone (17beta-hydroxyandrost-4-en-3-one); (63) Tetrahydrogestrinone (13beta,17alpha-diethyl-17beta-hydroxygon-4,9,11-trien-3-one); (64) Trenbolone (17beta-hydroxyestr-4,9,11-trien-3-one); (65) Any salt, ester, or ether of a drug or substance described in this paragraph. Except such term does not include an anabolic steroid that is expressly intended for administration through implants to cattle or other nonhuman species and that has been approved by the Secretary of Health and Human Services for such administration. If any person prescribes, dispenses, or distributes such steroid for human use, the person shall be considered to have prescribed, dispensed or distributed an anabolic steroid within the meaning of this paragraph. (g) Any material, compound, mixture or preparation which contains any quantity of buprenorphine or its salts. (h) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a United States Food and Drug Administration approved drug product. (i) Any material, compound, mixture, or preparation which contains any quantity of Tianeptine (7-((3-chloro-6-methyl-5,5-dioxido-6,11-dihydrodibenzo[c,f][1,2]thiazepin-11-yl)amino)heptanoic acid) or its salts, isomers, salts of isomers, sulfate, free acid or derivative thereof. (j) Any chemically synthesized compound, mixture, or preparation which contains any quantity of mitragynine, commonly known as kratom, (7 hydroxymitragynine and/or 7-OH-mitragynine) in excess of one percent (1%) of the total alkaloid composition of the kratom product. (B) Any material, compound, mixture or preparation which contains any quantity of a Schedule III controlled substance other than butalbital, and is listed as an exempt substance in 21 CFR, Section 1308.22, 1308.24, 1308.26, 1308.32 or 1308.34, shall be exempted from the provisions of the Uniform Controlled Substances Law. SECTION 2. This act shall take effect and be in force from and after July 1, 2025, and shall stand repealed on June 30, 2025.
1+MISSISSIPPI LEGISLATURE 2025 Regular Session To: Drug Policy; Judiciary, Division B By: Senator(s) Turner-Ford Senate Bill 2355 (COMMITTEE SUBSTITUTE) AN ACT TO AMEND SECTION 41-29-117, MISSISSIPPI CODE OF 1972, TO ADD ANY CHEMICALLY SYNTHESIZED COMPOUND, MIXTURE, OR PREPARATION OF KRATOM TO SCHEDULE III OF THE UNIFORM CONTROLLED SUBSTANCES ACT; AND FOR RELATED PURPOSES. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MISSISSIPPI: SECTION 1. Section 41-29-117, Mississippi Code of 1972, is amended as follows: 41-29-117. (A) The controlled substances listed in this section are included in Schedule III. SCHEDULE III (a) Stimulants. Any material, compound, mixture, or preparation which contains any quantity of the following substances or their salts, isomers, or salts of isomers, of the following substances: (1) Benzphetamine; (2) Chlorphentermine; (3) Clortermine; (4) Phendimetrazine. (b) Depressants. Unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances: (1) Any substance which contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid, except those substances which are specifically listed in other schedules; (2) Unless specifically excepted or unless listed in another schedule, any compound, mixture or preparation containing any of the following substances or any salt of the substances specifically included in this subsection (2) and one or more other active medicinal ingredients which are not listed in any other schedule: (i) Amobarbital; (ii) Secobarbital; (iii) Pentobarbital; (3) Any suppository dosage form containing any of the following substances or any salt of any of the substances specifically included in this subsection (3) approved by the Food and Drug Administration for marketing only as a suppository: (i) Amobarbital; (ii) Secobarbital; (iii) Pentobarbital; (4) Chlorhexadol; (5) Embutramide; (6) Any drug product containing gamma-hydroxybutyric acid, including its salts, isomers and salts of isomers, for which an application is approved under Section 505 of the Federal Food, Drug and Cosmetic Act; (7) Ketamine; its salts, isomers, and salts of isomers; other names include (+)-2-(2-chlorophenyl)-2-(methylamino)cyclohexanone; (8) Lysergic acid; (9) Lysergic acid amide; (10) Methyprylon; (11) Perampanel; its salts, isomers, and salts of isomers; (12) Sulfondiethylmethane; (13) Sulfonethylmethane; (14) Sulfonmethane; (15) Tiletamine and zolazepam or any salt thereof; other names for the tiletamine and zolazepam combination product include: telazol; other names for tiletamine include: 2-(ethylamino)-2-(2-thienyl)-cyclohexanone; other names for zolazepam include: 4-(2-fluorophenyl)-6,8-dihydro 1,3, 8-trimethylpyrazolo-[3,4-e](1,4)-diazepin-7(1H)-one, flupyrazapon. (c) Nalorphine. (d) Any material, compound, mixture or preparation which contains any quantity of ephedrine or pseudoephedrine, except for any product that contains any quantity of pseudoephedrine or ephedrine that is sold subject to the quantity restrictions authorized in Section 73-21-124. (e) Narcotic drugs. Any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or any salts thereof: (1) Not more than one and eight-tenths (1.8) grams of codeine, or any of its salts, per one hundred (100) milliliters or not more than ninety (90) milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium; (2) Not more than one and eight-tenths (1.8) grams of codeine, or any of its salts, per one hundred (100) milliliters or not more than ninety (90) milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts; (3) Not more than one and eight-tenths (1.8) grams of dihydrocodeine, or any of its salts, per one hundred (100) milliliters or not more than ninety (90) milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts; (4) Not more than three hundred (300) milligrams of ethylmorphine, or any of its salts, per one hundred (100) milliliters or not more than fifteen (15) milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts; (5) Not more than five hundred (500) milligrams of opium per one hundred (100) milliliters or per one hundred (100) grams, or not more than twenty-five (25) milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts; (6) Not more than fifty (50) milligrams of morphine, or any of its salts, per one hundred (100) milliliters or per one hundred (100) grams with one or more active, nonnarcotic ingredients in recognized therapeutic amounts. (f) Anabolic steroids. Unless specifically exempted or listed in another schedule, any material, compound, mixture or preparation containing any quantity of any of the following anabolic steroids (any drug or hormonal substance chemically and pharmacologically related to testosterone other than estrogens, progestins, corticosteroids and dehydroepiandrosterone): (1) 3beta,17-dihydroxy-5a-androstane; (2) 3alpha,17beta-dihydroxy-5a-androstane; (3) 5alpha-androstan-3,17-dione; (4) 1-androstenediol (3beta,17beta-dihydroxy-5alpha-androst-1-ene); (5) 1-androstenediol (3alpha,17beta-dihydroxy-5alpha-androst-1-ene); (6) 4-androstenediol (3beta,17beta-dihydroxy-androst-4-ene); (7) 5-androstenediol (3beta,17beta-dihydroxy-androst-5-ene); (8) 1-androstenedione ([5alpha]-androst-1-en-3, 17-dione); (9) 4-androstenedione (androst-4-en-3,17-dione); (10) 5-androstenedione (androst-5-en-3,17-dione); (11) Bolasterone (7alpha,17alpha-dimethyl-17beta-hydroxyandrost-4-en-3-one); (12) Boldenone (17beta-hydroxyandrost-1,4,-diene-3-one); (13) Boldione (androsta-1,4-diene-3,17-dione); (14) Calusterone (7beta,17alpha-dimethyl-17beta-hydroxyandrost-4-en-3-one); (15) Clostebol (4-chloro-17beta-hydroxyandrost-4-en-3-one); (16) Dehydrochloromethyltestosterone (4-chloro-17beta-hydroxy-17alpha-methylandrost-1,4-dien-3-one); (17) Desoxymethyltestosterone (17alpha-methyl-5alpha-androst-2-en-17beta-ol, also known as madol); (18) Delta1-dihydrotestosterone (also known as 1-testosterone) (17beta-hydroxy-5alpha-androst-1-en-3-one); (19) 4-dihydrotestosterone (17beta-hydroxy-androstan-3-one); (20) Drostanolone (17beta-hydroxy-2alpha-methyl-5alpha-androstan-3-one); (21) Ethylestrenol (17alpha-ethyl-17beta-hydroxyestr-4-ene); (22) Fluoxymesterone (9-fluoro-17alpha-methyl-11beta, 17beta-dihydroxyandrost-4-en-3-one); (23) Formebolone (2-formyl-17alpha-methyl-11alpha,17beta-dihydroxyandrost-1, 4-dien-3-one); (24) Furazabol (17alpha-methyl-17beta-hydroxyandrostano[2,3-c]-furazan); (25) 13 beta-ethyl-17alpha-hydroxy on-4-en-3-one; (26) 4-hydroxy testosterone (4,17beta-dihydroxyandrost-4-en-3-one); (27) 4-hydroxy-19-nortestosterone (4,17beta-dihydroxy-estr-4-en-3-one); (28) Mestanolone (17alpha-methyl-17beta-hydroxy-5-androstan-3-one); (29) Metergoline (alpha-methyl-17beta-hydroxy-[5alpha]-androstan-3-one); (30) Methandienone (17alpha-methyl-17beta-hydroxyandrost-1,4-dien-3-one); (31) Methandriol (17alpha-methyl-beta, 17beta-dihydroxyandrost-5-ene); (32) Metatron (2[alpha], 17[alpha]-dimethyl-5[alpha]-androstan-17[beta]-ol-3-one; (33) Methenolone (1-methyl-17beta-hydroxy-5alpha-androst-1-en-3-one); (34) 17alpha-methyl-beta, 17beta-dihydroxy-5a-androstane; (35) 17alpha-methyl-alpha, 17beta-dihydroxy-5a-androstane; (36) 17alpha-methyl-beta, 17beta-dihydroxyandrost-4-ene; (37) 17alpha-methyl-4-hydroxy nandrolone (17alpha-methyl-4-hydroxy-17beta-hydroxyestr-4-en-3-one); (38) Methyltrienolone (17alpha-methyl-17beta-hydroxyester-4,9(10)-dien-3-one); (39) Methyltrienolone (17alpha-methyl-17beta-hydroxyester-4,9-11-trine-3-one); (40) Methyltestosterone (17alpha-methyl-17beta-hydroxyandrost-4-en-3-one); (41) Mableton (7alpha,17alpha-dimethyl-17beta-hydroxyestr-4-en-3-one); (42) 17alpha-methyl-Delta1-dihydrotestosterone (17P beta-hydroxy-17alpha-methyl-5alpha-androst-1-en-3-one) (also known as 17-alpha-methyl-1-testosterone); (43) Nandrolone (17beta-hydroxyestr-4-en-3-one); (44) 19-nor-4-androstenediol (3beta,17beta-hydroxyester-4-ene); (45) 19-nor-4-androstenediol (Gambetta-hydroxyester-4-ene); (46) 19-nor-5-androstenediol (3beta,17beta-hydroxyester-5-ene); (47) 19-nor-5-androstenediol (3alpha,17beta-hydroxyester-5-ene); (48) 19-nor-4,9(10)-androstadiene Dione (estray-4,9(10)-diene3,17-dione, 19-norandrosta-4,9(10)-diene-3,17-dione); (49) 19-nor-4-androstenedione (estr-4-en-3,17-dione); (50) 19-nor-5-androstenedione (estr-5-en-3,17-dione); (51) Norbolethone (13beta,17alpha-diethyl-17beta-hydroxygon-4-en-3-one); (52) Norclostebol (4-chloro-17beta-hydroxyestr-4-en-3-one); (53) Norethandrolone (17alpha-ethyl-17beta-hydroxyestr-4-en-3-one); (54) Normethandrolone (17alpha-methyl-17beta-hydroxyestr-4-en-3-one); (55) Oxandrolone (17alpha-methyl-17beta-hydroxy-2-oxa-[5alpha]-androstan-3-one); (56) Oxymesterone (17alpha-methyl-4,17beta-dihydroxyandrost-4-en-3-one); (57) Oxymetholone (17alpha-methyl-2-hydroxymethylene-17beta-hydroxy-[5alpha]- androstan-3-one); (58) Prostanozol (17[beta]-hydroxy-5[alpha]-androstano[3,2-c]pyrazole) (59) Stanozolol (17alpha-methyl-17beta-hydroxy-[5alpha]-androst-2-eno[3,2-c]- pyrazole); (60) Stenbolone (17beta-hydroxy-2-methyl-[5alpha]-androst-1-en-3-one); (61) Testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone); (62) Testosterone (17beta-hydroxyandrost-4-en-3-one); (63) Tetrahydrogestrinone (13beta,17alpha-diethyl-17beta-hydroxygon-4,9,11-trien-3-one); (64) Trenbolone (17beta-hydroxyestr-4,9,11-trien-3-one); (65) Any salt, ester, or ether of a drug or substance described in this paragraph. Except such term does not include an anabolic steroid that is expressly intended for administration through implants to cattle or other nonhuman species and that has been approved by the Secretary of Health and Human Services for such administration. If any person prescribes, dispenses, or distributes such steroid for human use, the person shall be considered to have prescribed, dispensed or distributed an anabolic steroid within the meaning of this paragraph. (g) Any material, compound, mixture or preparation which contains any quantity of buprenorphine or its salts. (h) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a United States Food and Drug Administration approved drug product. (i) Any material, compound, mixture, or preparation which contains any quantity of Tianeptine (7-((3-chloro-6-methyl-5,5-dioxido-6,11-dihydrodibenzo[c,f][1,2]thiazepin-11-yl)amino)heptanoic acid) or its salts, isomers, salts of isomers, sulfate, free acid or derivative thereof. (j) Any chemically synthesized compound, mixture, or preparation which contains any quantity of mitragynine, commonly known as kratom, (7 hydroxymitragynine and/or 7-OH-mitragynine) in excess of one percent (1%) of the total alkaloid composition of the kratom product. (B) Any material, compound, mixture or preparation which contains any quantity of a Schedule III controlled substance other than butalbital, and is listed as an exempt substance in 21 CFR, Section 1308.22, 1308.24, 1308.26, 1308.32 or 1308.34, shall be exempted from the provisions of the Uniform Controlled Substances Law. SECTION 2. This act shall take effect and be in force from and after July 1, 2025.
22
33 MISSISSIPPI LEGISLATURE
44
55 2025 Regular Session
66
77 To: Drug Policy; Judiciary, Division B
88
99 By: Senator(s) Turner-Ford
1010
1111 # Senate Bill 2355
1212
13-## (As Passed the Senate)
13+## (COMMITTEE SUBSTITUTE)
1414
1515 AN ACT TO AMEND SECTION 41-29-117, MISSISSIPPI CODE OF 1972, TO ADD ANY CHEMICALLY SYNTHESIZED COMPOUND, MIXTURE, OR PREPARATION OF KRATOM TO SCHEDULE III OF THE UNIFORM CONTROLLED SUBSTANCES ACT; AND FOR RELATED PURPOSES.
1616
1717 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MISSISSIPPI:
1818
1919 SECTION 1. Section 41-29-117, Mississippi Code of 1972, is amended as follows:
2020
2121 41-29-117. (A) The controlled substances listed in this section are included in Schedule III.
2222
2323 SCHEDULE III
2424
2525 (a) Stimulants. Any material, compound, mixture, or preparation which contains any quantity of the following substances or their salts, isomers, or salts of isomers, of the following substances:
2626
2727 (1) Benzphetamine;
2828
2929 (2) Chlorphentermine;
3030
3131 (3) Clortermine;
3232
3333 (4) Phendimetrazine.
3434
3535 (b) Depressants. Unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:
3636
3737 (1) Any substance which contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid, except those substances which are specifically listed in other schedules;
3838
3939 (2) Unless specifically excepted or unless listed in another schedule, any compound, mixture or preparation containing any of the following substances or any salt of the substances specifically included in this subsection (2) and one or more other active medicinal ingredients which are not listed in any other schedule:
4040
4141 (i) Amobarbital;
4242
4343 (ii) Secobarbital;
4444
4545 (iii) Pentobarbital;
4646
4747 (3) Any suppository dosage form containing any of the following substances or any salt of any of the substances specifically included in this subsection (3) approved by the Food and Drug Administration for marketing only as a suppository:
4848
4949 (i) Amobarbital;
5050
5151 (ii) Secobarbital;
5252
5353 (iii) Pentobarbital;
5454
5555 (4) Chlorhexadol;
5656
5757 (5) Embutramide;
5858
5959 (6) Any drug product containing gamma-hydroxybutyric acid, including its salts, isomers and salts of isomers, for which an application is approved under Section 505 of the Federal Food, Drug and Cosmetic Act;
6060
6161 (7) Ketamine; its salts, isomers, and salts of isomers; other names include (+)-2-(2-chlorophenyl)-2-(methylamino)cyclohexanone;
6262
6363 (8) Lysergic acid;
6464
6565 (9) Lysergic acid amide;
6666
6767 (10) Methyprylon;
6868
6969 (11) Perampanel; its salts, isomers, and salts of isomers;
7070
7171 (12) Sulfondiethylmethane;
7272
7373 (13) Sulfonethylmethane;
7474
7575 (14) Sulfonmethane;
7676
7777 (15) Tiletamine and zolazepam or any salt thereof; other names for the tiletamine and zolazepam combination product include: telazol; other names for tiletamine include: 2-(ethylamino)-2-(2-thienyl)-cyclohexanone; other names for zolazepam include: 4-(2-fluorophenyl)-6,8-dihydro 1,3, 8-trimethylpyrazolo-[3,4-e](1,4)-diazepin-7(1H)-one, flupyrazapon.
7878
7979 (c) Nalorphine.
8080
8181 (d) Any material, compound, mixture or preparation which contains any quantity of ephedrine or pseudoephedrine, except for any product that contains any quantity of pseudoephedrine or ephedrine that is sold subject to the quantity restrictions authorized in Section 73-21-124.
8282
8383 (e) Narcotic drugs. Any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or any salts thereof:
8484
8585 (1) Not more than one and eight-tenths (1.8) grams of codeine, or any of its salts, per one hundred (100) milliliters or not more than ninety (90) milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium;
8686
8787 (2) Not more than one and eight-tenths (1.8) grams of codeine, or any of its salts, per one hundred (100) milliliters or not more than ninety (90) milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;
8888
8989 (3) Not more than one and eight-tenths (1.8) grams of dihydrocodeine, or any of its salts, per one hundred (100) milliliters or not more than ninety (90) milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;
9090
9191 (4) Not more than three hundred (300) milligrams of ethylmorphine, or any of its salts, per one hundred (100) milliliters or not more than fifteen (15) milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;
9292
9393 (5) Not more than five hundred (500) milligrams of opium per one hundred (100) milliliters or per one hundred (100) grams, or not more than twenty-five (25) milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;
9494
9595 (6) Not more than fifty (50) milligrams of morphine, or any of its salts, per one hundred (100) milliliters or per one hundred (100) grams with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.
9696
9797 (f) Anabolic steroids. Unless specifically exempted or listed in another schedule, any material, compound, mixture or preparation containing any quantity of any of the following anabolic steroids (any drug or hormonal substance chemically and pharmacologically related to testosterone other than estrogens, progestins, corticosteroids and dehydroepiandrosterone):
9898
9999 (1) 3beta,17-dihydroxy-5a-androstane;
100100
101101 (2) 3alpha,17beta-dihydroxy-5a-androstane;
102102
103103 (3) 5alpha-androstan-3,17-dione;
104104
105105 (4) 1-androstenediol (3beta,17beta-dihydroxy-5alpha-androst-1-ene);
106106
107107 (5) 1-androstenediol (3alpha,17beta-dihydroxy-5alpha-androst-1-ene);
108108
109109 (6) 4-androstenediol (3beta,17beta-dihydroxy-androst-4-ene);
110110
111111 (7) 5-androstenediol (3beta,17beta-dihydroxy-androst-5-ene);
112112
113113 (8) 1-androstenedione ([5alpha]-androst-1-en-3, 17-dione);
114114
115115 (9) 4-androstenedione (androst-4-en-3,17-dione);
116116
117117 (10) 5-androstenedione (androst-5-en-3,17-dione);
118118
119119 (11) Bolasterone (7alpha,17alpha-dimethyl-17beta-hydroxyandrost-4-en-3-one);
120120
121121 (12) Boldenone (17beta-hydroxyandrost-1,4,-diene-3-one);
122122
123123 (13) Boldione (androsta-1,4-diene-3,17-dione);
124124
125125 (14) Calusterone (7beta,17alpha-dimethyl-17beta-hydroxyandrost-4-en-3-one);
126126
127127 (15) Clostebol (4-chloro-17beta-hydroxyandrost-4-en-3-one);
128128
129129 (16) Dehydrochloromethyltestosterone (4-chloro-17beta-hydroxy-17alpha-methylandrost-1,4-dien-3-one);
130130
131131 (17) Desoxymethyltestosterone (17alpha-methyl-5alpha-androst-2-en-17beta-ol, also known as madol);
132132
133133 (18) Delta1-dihydrotestosterone (also known as 1-testosterone) (17beta-hydroxy-5alpha-androst-1-en-3-one);
134134
135135 (19) 4-dihydrotestosterone (17beta-hydroxy-androstan-3-one);
136136
137137 (20) Drostanolone (17beta-hydroxy-2alpha-methyl-5alpha-androstan-3-one);
138138
139139 (21) Ethylestrenol (17alpha-ethyl-17beta-hydroxyestr-4-ene);
140140
141141 (22) Fluoxymesterone (9-fluoro-17alpha-methyl-11beta, 17beta-dihydroxyandrost-4-en-3-one);
142142
143143 (23) Formebolone (2-formyl-17alpha-methyl-11alpha,17beta-dihydroxyandrost-1, 4-dien-3-one);
144144
145145 (24) Furazabol (17alpha-methyl-17beta-hydroxyandrostano[2,3-c]-furazan);
146146
147147 (25) 13 beta-ethyl-17alpha-hydroxy on-4-en-3-one;
148148
149149 (26) 4-hydroxy testosterone (4,17beta-dihydroxyandrost-4-en-3-one);
150150
151151 (27) 4-hydroxy-19-nortestosterone (4,17beta-dihydroxy-estr-4-en-3-one);
152152
153153 (28) Mestanolone (17alpha-methyl-17beta-hydroxy-5-androstan-3-one);
154154
155155 (29) Metergoline (alpha-methyl-17beta-hydroxy-[5alpha]-androstan-3-one);
156156
157157 (30) Methandienone (17alpha-methyl-17beta-hydroxyandrost-1,4-dien-3-one);
158158
159159 (31) Methandriol (17alpha-methyl-beta, 17beta-dihydroxyandrost-5-ene);
160160
161161 (32) Metatron (2[alpha], 17[alpha]-dimethyl-5[alpha]-androstan-17[beta]-ol-3-one;
162162
163163 (33) Methenolone (1-methyl-17beta-hydroxy-5alpha-androst-1-en-3-one);
164164
165165 (34) 17alpha-methyl-beta, 17beta-dihydroxy-5a-androstane;
166166
167167 (35) 17alpha-methyl-alpha, 17beta-dihydroxy-5a-androstane;
168168
169169 (36) 17alpha-methyl-beta, 17beta-dihydroxyandrost-4-ene;
170170
171171 (37) 17alpha-methyl-4-hydroxy nandrolone (17alpha-methyl-4-hydroxy-17beta-hydroxyestr-4-en-3-one);
172172
173173 (38) Methyltrienolone (17alpha-methyl-17beta-hydroxyester-4,9(10)-dien-3-one);
174174
175175 (39) Methyltrienolone (17alpha-methyl-17beta-hydroxyester-4,9-11-trine-3-one);
176176
177177 (40) Methyltestosterone (17alpha-methyl-17beta-hydroxyandrost-4-en-3-one);
178178
179179 (41) Mableton (7alpha,17alpha-dimethyl-17beta-hydroxyestr-4-en-3-one);
180180
181181 (42) 17alpha-methyl-Delta1-dihydrotestosterone (17P beta-hydroxy-17alpha-methyl-5alpha-androst-1-en-3-one) (also known as 17-alpha-methyl-1-testosterone);
182182
183183 (43) Nandrolone (17beta-hydroxyestr-4-en-3-one);
184184
185185 (44) 19-nor-4-androstenediol (3beta,17beta-hydroxyester-4-ene);
186186
187187 (45) 19-nor-4-androstenediol (Gambetta-hydroxyester-4-ene);
188188
189189 (46) 19-nor-5-androstenediol (3beta,17beta-hydroxyester-5-ene);
190190
191191 (47) 19-nor-5-androstenediol (3alpha,17beta-hydroxyester-5-ene);
192192
193193 (48) 19-nor-4,9(10)-androstadiene Dione (estray-4,9(10)-diene3,17-dione, 19-norandrosta-4,9(10)-diene-3,17-dione);
194194
195195 (49) 19-nor-4-androstenedione (estr-4-en-3,17-dione);
196196
197197 (50) 19-nor-5-androstenedione (estr-5-en-3,17-dione);
198198
199199 (51) Norbolethone (13beta,17alpha-diethyl-17beta-hydroxygon-4-en-3-one);
200200
201201 (52) Norclostebol (4-chloro-17beta-hydroxyestr-4-en-3-one);
202202
203203 (53) Norethandrolone (17alpha-ethyl-17beta-hydroxyestr-4-en-3-one);
204204
205205 (54) Normethandrolone (17alpha-methyl-17beta-hydroxyestr-4-en-3-one);
206206
207207 (55) Oxandrolone (17alpha-methyl-17beta-hydroxy-2-oxa-[5alpha]-androstan-3-one);
208208
209209 (56) Oxymesterone (17alpha-methyl-4,17beta-dihydroxyandrost-4-en-3-one);
210210
211211 (57) Oxymetholone (17alpha-methyl-2-hydroxymethylene-17beta-hydroxy-[5alpha]- androstan-3-one);
212212
213213 (58) Prostanozol
214214
215215 (17[beta]-hydroxy-5[alpha]-androstano[3,2-c]pyrazole)
216216
217217 (59) Stanozolol (17alpha-methyl-17beta-hydroxy-[5alpha]-androst-2-eno[3,2-c]- pyrazole);
218218
219219 (60) Stenbolone (17beta-hydroxy-2-methyl-[5alpha]-androst-1-en-3-one);
220220
221221 (61) Testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone);
222222
223223 (62) Testosterone (17beta-hydroxyandrost-4-en-3-one);
224224
225225 (63) Tetrahydrogestrinone (13beta,17alpha-diethyl-17beta-hydroxygon-4,9,11-trien-3-one);
226226
227227 (64) Trenbolone (17beta-hydroxyestr-4,9,11-trien-3-one);
228228
229229 (65) Any salt, ester, or ether of a drug or substance described in this paragraph. Except such term does not include an anabolic steroid that is expressly intended for administration through implants to cattle or other nonhuman species and that has been approved by the Secretary of Health and Human Services for such administration. If any person prescribes, dispenses, or distributes such steroid for human use, the person shall be considered to have prescribed, dispensed or distributed an anabolic steroid within the meaning of this paragraph.
230230
231231 (g) Any material, compound, mixture or preparation which contains any quantity of buprenorphine or its salts.
232232
233233 (h) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a United States Food and Drug Administration approved drug product.
234234
235235 (i) Any material, compound, mixture, or preparation which contains any quantity of Tianeptine (7-((3-chloro-6-methyl-5,5-dioxido-6,11-dihydrodibenzo[c,f][1,2]thiazepin-11-yl)amino)heptanoic acid) or its salts, isomers, salts of isomers, sulfate, free acid or derivative thereof.
236236
237237 (j) Any chemically synthesized compound, mixture, or preparation which contains any quantity of mitragynine, commonly known as kratom, (7 hydroxymitragynine and/or 7-OH-mitragynine) in excess of one percent (1%) of the total alkaloid composition of the kratom product.
238238
239239 (B) Any material, compound, mixture or preparation which contains any quantity of a Schedule III controlled substance other than butalbital, and is listed as an exempt substance in 21 CFR, Section 1308.22, 1308.24, 1308.26, 1308.32 or 1308.34, shall be exempted from the provisions of the Uniform Controlled Substances Law.
240240
241- SECTION 2. This act shall take effect and be in force from and after July 1, 2025, and shall stand repealed on June 30, 2025.
241+ SECTION 2. This act shall take effect and be in force from and after July 1, 2025.